Add to ORKGPregnant and breastfeeding populations are at substantial risk of acquiring HIV in some settings, yet are underrepresented in clinical trials of new pre-exposure prophylaxis (PrEP) agents. Several PrEP formulations are in development (eg, vaginal rings, long-acting injectables, and other modalities). Pregnant and breastfeeding populations are typically excluded from initial clinical trials. We identified 14 PrEP trials of novel agents in non-pregnant or non-breastfeeding populations, and six phase 1-3 trials and open label extensions among pregnant and breastfeeding populations, that are currently ongoing or complete. A framework shift is needed to consider the ethical costs of excluding pregnant and breastfeeding populations at risk for HI...
To optimize scale-up of pre-exposure prophylaxis (PrEP) for pregnant women at risk of HIV in high HI...
Pregnant and postpartum women in Southern Africa are at increased risk of HIV infection. Pre-exposur...
Pre-exposure prophylaxis (PrEP) uptake remains woefully low among U.S. women at high risk for HIV ac...
IntroductionHIV incidence is high during pregnancy and breastfeeding with HIV acquisition risk more ...
IntroductionHIV prevention during pregnancy and lactation is critical for both maternal and child he...
High HIV incidence rates have been observed among pregnant and breastfeeding women in sub-Saharan Af...
Abstract Though many women in need of access to HIV preventive regimes are pregnant, there is a dear...
Pregnancy is a high-risk period for HIV acquisition in African women, and pregnant women who become ...
Information on the extent of drug exposure to mothers and infants during pregnancy and lactation nor...
Item does not contain fulltextInformation on the extent of drug exposure to mothers and infants duri...
Thesis (Ph.D.)--University of Washington, 2017-06Women in sub-Saharan Africa have substantial risk o...
There are ~900,000 new HIV infections among women every year, representing nearly half of all new HI...
Information on the extent of drug exposure to mothers and infants during pregnancy and lactation nor...
BACKGROUND: Adolescent girls and young women (AGYW) in South Africa are at a higher risk of acquirin...
As pre-exposure prophylaxis (PrEP) becomes more widely used in heterosexual populations, an importan...
To optimize scale-up of pre-exposure prophylaxis (PrEP) for pregnant women at risk of HIV in high HI...
Pregnant and postpartum women in Southern Africa are at increased risk of HIV infection. Pre-exposur...
Pre-exposure prophylaxis (PrEP) uptake remains woefully low among U.S. women at high risk for HIV ac...
IntroductionHIV incidence is high during pregnancy and breastfeeding with HIV acquisition risk more ...
IntroductionHIV prevention during pregnancy and lactation is critical for both maternal and child he...
High HIV incidence rates have been observed among pregnant and breastfeeding women in sub-Saharan Af...
Abstract Though many women in need of access to HIV preventive regimes are pregnant, there is a dear...
Pregnancy is a high-risk period for HIV acquisition in African women, and pregnant women who become ...
Information on the extent of drug exposure to mothers and infants during pregnancy and lactation nor...
Item does not contain fulltextInformation on the extent of drug exposure to mothers and infants duri...
Thesis (Ph.D.)--University of Washington, 2017-06Women in sub-Saharan Africa have substantial risk o...
There are ~900,000 new HIV infections among women every year, representing nearly half of all new HI...
Information on the extent of drug exposure to mothers and infants during pregnancy and lactation nor...
BACKGROUND: Adolescent girls and young women (AGYW) in South Africa are at a higher risk of acquirin...
As pre-exposure prophylaxis (PrEP) becomes more widely used in heterosexual populations, an importan...
To optimize scale-up of pre-exposure prophylaxis (PrEP) for pregnant women at risk of HIV in high HI...
Pregnant and postpartum women in Southern Africa are at increased risk of HIV infection. Pre-exposur...
Pre-exposure prophylaxis (PrEP) uptake remains woefully low among U.S. women at high risk for HIV ac...